Asia-Pacific Forum on Access and Sustainability of PCV: Data needs for decision-making

By Murdoch Children's Research Institute

The COVID-19 pandemic has shed light on global vaccine inequity, but this inequity has been longstanding and exists for all new and underutilised vaccines in low and middle income countries. The budget impact of COVID-19 vaccine has been enormous. Access and sustainability of other important vaccines, including the pneumococcal conjugate vaccine (PCV), needs to continue. This vaccine is key in preventing childhood pneumonia, the biggest cause of child deaths globally.

This three-day forum will provide a platform for multidisciplinary pneumococcal experts, academics, governments, policymakers and health organisations to discuss:

• The access and sustainability of PCV in the Asia-Pacific region;
• Key research needed to inform policy decisions; and
• How to support the development of research capacity in the region.

This event will feature speakers from academic institutions and governments from the Asia-Pacific region, as well as from the Australian Department of Foreign Affairs and Trade (DFAT), World Health Organization (WHO), members of the WHO Strategic Advisory Group of Experts (SAGE), UNICEF, the Australian Technical Advisory Group on Immunisation (ATAGI), and leading international pneumococcal experts.

Please see below for full details of the program.

Please note that this is an online event. For any attendees who would like to attend in-person, please select this option on the registration page.